Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 5
2008 9
2009 13
2010 21
2011 33
2012 25
2013 26
2014 15
2015 23
2016 9
2017 10
2018 15
2019 9
2020 13
2021 49
2022 38
2023 25
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Results by year

Filters applied: . Clear all
Page 1
Airborne transmission of SARS-CoV-2 disease (COVID-19).
Parvez MK, Parveen S. Parvez MK, et al. Future Virol. 2022 Feb:10.2217/fvl-2021-0324. doi: 10.2217/fvl-2021-0324. Epub 2022 Mar 1. Future Virol. 2022. PMID: 35251292 Free PMC article. No abstract available.
Reinfection and reactivation of SARS-CoV-2.
Dowran R, Damavandi AR, Azad TM. Dowran R, et al. Future Virol. 2022 Sep:10.2217/fvl-2021-0212. doi: 10.2217/fvl-2021-0212. Epub 2022 Sep 26. Future Virol. 2022. PMID: 36176508 Free PMC article. Review.
Can anti-parasitic drugs help control COVID-19?
Panahi Y, Dadkhah M, Talei S, Gharari Z, Asghariazar V, Abdolmaleki A, Matin S, Molaei S. Panahi Y, et al. Future Virol. 2022 Mar:10.2217/fvl-2021-0160. doi: 10.2217/fvl-2021-0160. Epub 2022 Mar 18. Future Virol. 2022. PMID: 35359702 Free PMC article. Review.
A comprehensive review about SARS-CoV-2.
Haque SM, Ashwaq O, Sarief A, Azad John Mohamed AK. Haque SM, et al. Future Virol. 2020 Sep;15(9):625-648. doi: 10.2217/fvl-2020-0124. Future Virol. 2020. PMID: 33224265 Free PMC article. Review.
Harnessing immunological targets for COVID-19 immunotherapy.
Mehata AK, Viswanadh MK, Priya V, Vikas, Muthu MS. Mehata AK, et al. Future Virol. 2021 Jul:10.2217/fvl-2021-0048. doi: 10.2217/fvl-2021-0048. Epub 2021 Aug 9. Future Virol. 2021. PMID: 34447458 Free PMC article. Review.
Membrane binding proteins of coronaviruses.
J Alsaadi EA, Jones IM. J Alsaadi EA, et al. Future Virol. 2019 Apr;14(4):275-286. doi: 10.2217/fvl-2018-0144. Epub 2019 Apr 29. Future Virol. 2019. PMID: 32201500 Free PMC article. Review.
Toll-like receptor 4 in COVID-19: friend or foe?
Mukherjee S. Mukherjee S. Future Virol. 2022 Mar:10.2217/fvl-2021-0249. doi: 10.2217/fvl-2021-0249. Epub 2022 Apr 19. Future Virol. 2022. PMID: 35462619 Free PMC article.
Designing and building oncolytic viruses.
Maroun J, Muñoz-Alía M, Ammayappan A, Schulze A, Peng KW, Russell S. Maroun J, et al. Future Virol. 2017 Apr;12(4):193-213. doi: 10.2217/fvl-2016-0129. Epub 2017 Mar 31. Future Virol. 2017. PMID: 29387140 Free PMC article. Review.
335 results